Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
PLoS One ; 3(12): e3910, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19079548

RESUMO

Aging is associated with a progressive loss of muscle mass, increased adiposity and fibrosis that leads to sarcopenia. At the molecular level, muscle aging is known to alter the expression of a variety of genes but very little is known about the molecular effectors involved. SRF (Serum Response Factor) is a crucial transcription factor for muscle-specific gene expression and for post-natal skeletal muscle growth. To assess its role in adult skeletal muscle physiology, we developed a post-mitotic myofiber-specific and tamoxifen-inducible SRF knockout model. Five months after SRF loss, no obvious muscle phenotype was observed suggesting that SRF is not crucial for myofiber maintenance. However, mutant mice progressively developed IIB myofiber-specific atrophy accompanied by a metabolic switch towards a more oxidative phenotype, muscular lipid accumulation, sarcomere disorganization and fibrosis. After injury, mutant muscles exhibited an altered regeneration process, showing smaller regenerated fibers and persistent fibrosis. All of these features are strongly reminiscent of abnormalities encountered in aging skeletal muscle. Interestingly, we also observed an important age associated decrease in SRF expression in mice and human muscles. Altogether, these results suggest that a naturally occurring SRF down-regulation precedes and contributes to the muscle aging process. Indeed, triggering SRF loss in the muscles of mutant mice results in an accelerated aging process.


Assuntos
Senilidade Prematura/patologia , Músculo Esquelético/patologia , Fator de Resposta Sérica/deficiência , Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/metabolismo , Animais , Regulação para Baixo/efeitos dos fármacos , Fibrose , Humanos , Técnicas In Vitro , Metabolismo dos Lipídeos/efeitos dos fármacos , Camundongos , Camundongos Knockout , Camundongos Mutantes , Fibras Musculares Esqueléticas/efeitos dos fármacos , Fibras Musculares Esqueléticas/patologia , Fibras Musculares Esqueléticas/ultraestrutura , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/ultraestrutura , Atrofia Muscular/patologia , Regeneração/efeitos dos fármacos , Reprodutibilidade dos Testes , Sarcômeros/efeitos dos fármacos , Sarcômeros/patologia , Sarcômeros/ultraestrutura , Fator de Resposta Sérica/genética , Tamoxifeno/administração & dosagem , Tamoxifeno/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA